Effects of Moving Training on Histology and Biomarkers Levels of Articular Cartilage

Journal of Surgical Research

Volumn 135, Issue 2, 2006, Pages 352-363

  Qi, Chang ^a   Changlin, Huang ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b The 150th Central Hospital of People's Liberation Army   (China)

Author keywords

analysis; biological markers; cartilage; injuries; joints

Indexed keywords

BIOLOGICAL MARKER; CARTILAGE OLIGOMERIC MATRIX PROTEIN; INTERSTITIAL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CONTROLLED STUDY; DOG; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; KNEE; MALE; MOVEMENT (PHYSIOLOGY); NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SERUM; SPORT INJURY; STATISTICAL SIGNIFICANCE; SYNOVIAL FLUID; TRAINING;

ANIMALS; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; GLYCOPROTEINS; HINDLIMB; MAGNETIC RESONANCE IMAGING; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MOVEMENT; PHYSICAL CONDITIONING, ANIMAL; SYNOVIAL FLUID; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 33748792022     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.03.011     Document Type: Article

References (48)

1. Recht M.P., Piraino D.W., Paletta G.A., et al. Accuracy of fat-suppressed three-dimensional spoiled gradient-echo FLASH MR imaging in the detection of patellofemoral articular cartilage abnormalities. Radiology 198 (1996) 209
2. Bredella M.A., Tirman P.F., Peterfy C.G., et al. Accuracy of T2-weighted fast spin-echo MR imaging with fat saturation in detecting cartilage defects in the knee: comparison with arthroscopy in 130 patients. AJR Am J Roentgenol 172 (1999) 1073
3. Herold T., Lenhart M., Held P., et al. Indirect MR arthrography of the wrist in the diagnosis of TFCC-Lesions. Rofo 173 (2001) 1006
4. Garnero P. Osteoarthritis: biological markers for the future?. Joint Bone Spine 69 (2002) 525
5. Mankin H.J., Dorfman H., Lippiello L., et al. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 53 (1971) 523
6. Vilim V., Lenz M.E., Vytasek R., et al. Characterization of monoclonal antibodies recognizing different fragments of cartilage oligomeric matrix protein in human body fluids. Arch Biochem Biophys 341 (1997) 8
7. Vilim V., Vytasek R., Olejarova M., et al. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis. Osteoarthritis Cartilage 9 (2001) 612
8. Naito K., Takahashi M., Kushida K., et al. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis. Rheumatology (Oxford) 38 (1999) 510
9. Buckwalter J.A., and Lane N.E. Athletics and osteoarthritis. Am J Sports Med 25 (1997) 873
10. Dekel S., and Weissman S.L. Joint changes after overuse and peak overloading of rabbit knees in vivo. Acta Orthop Scand 49 (1978) 519
11. Hunziker E.B., Quinn T.M., and Hauselmann H.J. Quantitative structural organization of normal adult human articular cartilage. Osteoarthritis Cartilage 10 (2002) 564
12. Carlson C.S., Guilak F., Vail T.P., et al. Synovial fluid biomarker levels predict articular cartilage damage following complete medial meniscectomy in the canine knee. J Orthop Res 20 (2002) 92
13. Skioldebrand E., Heinegard D., Eloranta M.L., et al. Enhanced concentration of COMP (cartilage oligomeric matrix protein) in osteochondral fractures from racing thoroughbreds. J Orthop Res 23 (2005) 156
14. Larsson E., Erlandsson, Harris H., et al. Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats. Rheumatology (Oxford) 41 (2002) 996
15. Dragomir A.D., Kraus V.B., Renner J.B., et al. Serum cartilage oligomeric matrix protein and clinical signs and symptoms of potential pre-radiographic hip and knee pathology. Osteoarthritis Cartilage 10 (2002) 687
16. Oldberg A., Antonsson P., Lindblom K., et al. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem 267 (1992) 22346
17. Morgelin M., Heinegard D., Engel J., et al. Electron microscopy of native cartilage oligomeric matrix protein purified from the swarm rat chondrosarcoma reveals a five-armed structure. J Biol Chem 267 (1992) 6137
18. Efimov V.P., Lustig A., and Engel J. The thrombospondin-like chains of cartilage oligomeric matrix protein are assembled by a five-stranded alpha-helical bundle between residues 20 and 83. FEBS Lett 341 (1994) 54
19. Recklies A.D., Baillargeon L., and White C. Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes. Arthritis Rheum 41 (1998) 997
20. Di Cesare P.E., Fang C., Leslie M.P., et al. Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblasts. J Orthop Res 18 (2000) 713
21. DiCesare P.E., Morgelin M., Carlson C.S., et al. Cartilage oligomeric matrix protein: isolation and characterization from human articular cartilage. J Orthop Res 13 (1995) 422
22. DiCesare P., Hauser N., Lehman D., et al. Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon. FEBS Lett 354 (1994) 237
23. Murphy J.M., Heinegard R., McIntosh A., et al. Distribution of cartilage molecules in the developing mouse joint. Matrix Biol 18 (1999) 487
24. Skioldebrand E., Lorenzo P., Zunino L., et al. Concentration of collagen, aggrecan and cartilage oligomeric matrix protein (COMP) in synovial fluid from equine middle carpal joints. Equine Vet J 33 (2001) 394
25. Briggs M.D., Hoffman S.M., King L.M., et al. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet 10 (1995) 330
26. Hecht J.T., Nelson L.D., Crowder E., et al. Mutations in Exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nat Genet 10 (1995) 325
27. Vilim V., Olejarova M., Machacek S., et al. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 10 (2002) 707
28. Petersson I.F., Sandqvist L., Svensson B., et al. Cartilage markers in synovial fluid in symptomatic knee osteoarthritis. Ann Rheum Dis 56 (1997) 64
29. Vingsbo-Lundberg C., Saxne T., Olsson H., et al. Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats. Arthritis Rheum 41 (1998) 544
30. Larsson E., Mussener A., Heinegard D., et al. Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis. Br J Rheumatol 36 (1997) 1258-1261
31. Joosten L.A., Helsen M.M., Saxne T., et al. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J Immunol 163 (1999) 5049
32. Neidhart M., Muller-Ladner U., Frey W., et al. Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners. Osteoarthritis Cartilage 8 (2000) 222
33. Jain A., Nanchahal J., Troeberg L., et al. Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis. Arthritis Rheum 44 (2001) 1754
34. Jingushi S., Lohmander L.S., Shinmei M., et al. Markers of joint tissue turnover in joint fluids from hips with osteonecrosis of the femoral head. J Orthop Res 18 (2000) 728
35. Schmidt-Rohlfing B., Gavenis K., Kippels M., et al. New potential markers for cartilage degradation of the knee joint. Scand J Rheumatol 31 (2002) 151
36. Billinghurst R.C., Dahlberg L., Ionescu M., et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 99 (1997) 1534
37. Roberts S., Caterson B., Menage J., et al. Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc. Spine 25 (2000) 3005
38. Nagase H. Human stromelysins 1 and 2. Methods Enzymol 248 (1995) 449
39. Wu J.J., Lark M.W., Chun L.E., et al. Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. J Biol Chem 266 (1991) 5625
40. Martel-Pelletier J. Pathophysiology of osteoarthritis. Osteoarthritis Cartilage 7 (1999) 371
41. Bonassar L.J., Stinn J.L., Paguio C.G., et al. Activation and inhibition of endogenous matrix metalloproteinases in articular cartilage: effects on composition and biophysical properties. Arch Biochem Biophys 333 (1996) 359
42. Su S., Grover J., Roughley P.J., et al. Expression of the tissue inhibitor of metalloproteinases (TIMP) gene family in normal and osteoarthritic joints. Rheumatol Int 18 (1999) 183
43. Fosang A.J., Last K., and Maciewicz R.A. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent. J Clin Invest 98 (1996) 2292
44. Handa T., Ishihara H., Ohshima H., et al. Effects of hydrostatic pressure on matrix synthesis and matrix metalloproteinase production in the human lumbar intervertebral disc. Spine 22 (1997) 1085
45. Fernandez-Madrid F., Karvonen R.L., Teitge R.A., et al. MR features of osteoarthritis of the knee. Magn Reson Imaging 12 (1994) 703
46. Lysholm J., Hamberg P., and Gillquist J. The correlation between osteoarthrosis as seen on radiographs and on arthroscopy. Arthroscopy 3 (1987) 161
47. Young-Min S.A., Cawston T.E., and Griffiths I.D. Markers of joint destruction: principles, problems, and potential. Ann Rheum Dis 60 (2001) 545
48. Manicourt D.H., Poilvache P., Nzeusseu A., et al. Serum levels of hyaluronan, antigenic keratan sulfate, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 change predictably in rheumatoid arthritis patients who have begun activity after a night of bed rest. Arthritis Rheum 42 (1999) 1861